Collins Stewart Reiterates a 'Buy' on Valeant Pharmaceuticals (VRX); Weakness Related To CEPH Is A Good Buying Opportunity May 2, 2011 03:02PM
Wall Street Mixed On Additional Upside in Cephalon (CEPH) Following Takeover Bid Mar 30, 2011 03:36PM
Collins Stewart Cuts Price Target on Cephalon (CEPH) Following Possible Release of A Generic Fentora Mar 14, 2011 09:37AM
Collins Stewart Initiates Coverage on Cephalon (CEPH) with a Hold Apr 22, 2009 11:51AM